Ricardo Helman1, Fabio Pires de Souza Santos1, Belinda Simões2, Elias Hallack Atta3, Fernando Callera4, Jane de Almeida Dobbin5, Éderson Roberto Mattos6, Angelo Atalla7, Angelo Maiolino8, Maria Aparecida Zanichelli9, Cristiane Fração Diefenbach10, Marcia Torresan Delamain11, Nelson Hamerschlak1. 1. Hospital Israelita Albert Einstein - HIAE, São Paulo, BR. 2. Medical College, Hospital das Clínicas, Universidade de São Paulo - USP, Ribeirão Preto, SP, BR. 3. Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti - HEMORIO, Rio de Janeiro, RJ, BR. 4. Hospital Pio XII, São José dos Campos, SP, BR. 5. Instituto Nacional do Câncer - INCA, Rio de Janeiro, RJ, BR. 6. Hospital Amaral Carvalho - Jaú, Jaú, SP, BR. 7. Universidade Federal de Juiz Fora - UFJF, Juiz de Fora, MG, BR. 8. Universidade Federal do Rio de Janeiro - UFRJ, Rio de Janeiro, RJ, BR. 9. Hospital de Transplantes, Estado de São Paulo Dr. Euryclides de Jesus Zerbini, São Paulo, SP, BR. 10. Hospital Universitário de Santa Maria, Santa Maria, RS, BR. 11. Hematology and Hemotherapy Center, Universidade Estadual de Campinas - UNICAMP, Campinas, SP, BR.
Abstract
OBJECTIVE: To identify how the Brazilian hematology centers treated and diagnosed cases of acute myeloid leukemia in 2009. METHODS: An epidemiological observational multicenter study of 11 listed Brazilian centers that treat acute myeloid leukemia and perform bone marrow transplantation. Data were collected from clinical charts of patients with acute myeloid leukemia treated at the said centers between 2005 and 2009. The availability for immunophenotyping and cytogenetic tests was assessed. RESULTS: During 2009, a total of 345 new cases of acute myeloid leukemia were diagnosed. Differences were noted in the tests performed between patients who initiated treatment at the center and those referred for treatment. Of the participating centers, 72% conducted some type of molecular study in acute myeloid leukemia upon diagnosis. CONCLUSION: Treatment for acute myeloid leukemia in Brazil shows significantly inferior results when compared to other centers worldwide.
OBJECTIVE: To identify how the Brazilian hematology centers treated and diagnosed cases of acute myeloid leukemia in 2009. METHODS: An epidemiological observational multicenter study of 11 listed Brazilian centers that treat acute myeloid leukemia and perform bone marrow transplantation. Data were collected from clinical charts of patients with acute myeloid leukemia treated at the said centers between 2005 and 2009. The availability for immunophenotyping and cytogenetic tests was assessed. RESULTS: During 2009, a total of 345 new cases of acute myeloid leukemia were diagnosed. Differences were noted in the tests performed between patients who initiated treatment at the center and those referred for treatment. Of the participating centers, 72% conducted some type of molecular study in acute myeloid leukemia upon diagnosis. CONCLUSION: Treatment for acute myeloid leukemia in Brazil shows significantly inferior results when compared to other centers worldwide.